代谢稳定性测定

录制类型:Evaluation

Studies measure compound half-life, calculate intrinsic clearance and predict human pharmacokinetic (PK) profiles in anticipation of first-in-human (FIH) trials.

Disappearance of a parent compound or the appearance of metabolites is measured following incubation with hepatocytes, liver microsomes or plasma, enabling calculations of half-life and intrinsic clearance.

然后可以阐明测试制品和代谢物谱的生物转化。

分子或产品类型

Small Molecule,Biologics

法规

Ind&CTA.

行业市场

制药

阶段

Nonclinical